An Optimized Protocol for Human Direct Cardiac Reprogramming
Authors:
Open Access
- 1 June 2020
- journal article
- research article
- Published by Elsevier in STAR Protocols
- Vol. 1 (1)
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute (AHA 18TPA34180058, R01HL128331, R01HL139880, R01HL139976, R01HL144551, NIH T32 HL069768)
- University of North Carolina (AHA 18TPA34180058, R01HL128331, R01HL139880, R01HL139976, R01HL144551, NIH T32 HL069768)
This publication has 11 references indexed in Scilit:
- Single-Cell Transcriptomic Analyses of Cell Fate Transitions during Human Cardiac ReprogrammingCell Stem Cell, 2019
- Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vectorScientific Reports, 2017
- Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5Journal of Visualized Experiments, 2015
- Stoichiometry of Gata4, Mef2c, and Tbx5 Influences the Efficiency and Quality of Induced Cardiac Myocyte ReprogrammingCirculation Research, 2015
- Direct Reprogramming of Human Fibroblasts toward a Cardiomyocyte-like StateStem Cell Reports, 2013
- Reprogramming of mouse fibroblasts into cardiomyocyte-like cells in vitroNature Protocols, 2013
- Reprogramming of human fibroblasts toward a cardiac fateProceedings of the National Academy of Sciences, 2013
- Quantitative Comparison of Constitutive Promoters in Human ES cellsPLOS ONE, 2010
- Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined FactorsCell, 2010
- Analysis of Different Promoter Systems for Efficient Transgene Expression in Mouse Embryonic Stem Cell LinesStem Cells, 2002